Skip to content

EACS: Once-a-day Kaletra can be risky

EACS: Hospital admissions and appointments predict subsequent HIV diagnosis and death

EACS: One in five UK patients remains on failing therapy for over a year

Bevirimat 300mg oral solution dose does well in study

Women who don't have enough to eat taking more sexual risks in Africa

Boosted saquinavir as good as Kaletra, Gemini study shows

Girls aged 12 and 13 to get HPV vaccination in England, two year catch-up to vaccinate girls aged up to 18

Once-daily nevirapine doesn't improve adherence, may increase risk of treatment break and resistance

Paradox: people with moderate viral load more likely to pass on HIV